Trump's signature policy is 'collapsing under basic arithmetic': analysis

U.S. President Donald Trump attends an event to announce a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White House in Washington, D.C.